Phase III Success: Elobixibat Enhances Constipation Relief and Quality of Life

*Showing improvement across all follow-up periods.

CSBM: Complete spontaneous bowel movement; JPAC-QOL: Japanese patient assessment of constipation quality of life; n: Number of patients; SBM: Spontaneous bowel movement.

Reference: Nakajima A, Seki M, Taniguchi S, et al. Safety and efficacy of elobixibat for chronic constipation: Results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Lancet Gastroenterol Hepatol. 2018;3(8):537–547.

For the use of a Registered Medical Practitioner, Hospital or a Laboratory only.    GGI-CO-A1-AQS-300041570-ELC-J24-1192